VB

Vimla Bansal

Active Director Director DIN 09333643
DIN 09333643 First appointment Sep 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Vimla Bansal

Data last updated:

Vimla Bansal is a Director at Zags Healthcare Private Limited (since 2021). The company operates in Pharma.

DIN 09333643
Primary Designation Director
Industry Pharma
First Appointment 25 Sep 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zags Healthcare Private Limited U24230MP2021PTC057634
Director25 Sep 20212021Active

Directorship timeline

Open interactive timeline →
Zags Healthcare Private Limited
Premium access

Shareholding and investment profile for Vimla Bansal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vimla Bansal

Vimla Bansal currently holds 1 directorship: Zags Healthcare Private Limited (Director, since 25 Sep 2021).

Vimla Bansal was first appointed on 25 Sep 2021 as Director at Zags Healthcare Private Limited.

The current boards of Vimla Bansal's companies include Deepak Agrawal (Zags Healthcare Private Limited), Girish Arora (Zags Healthcare Private Limited), Pratistha Dalmia (Zags Healthcare Private Limited), Priyamvada Bhasin (Zags Healthcare Private Limited), Sandhya Gupta (Zags Healthcare Private Limited), Shikha Upadhyay (Zags Healthcare Private Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available